Ekso Bionics

Ekso Bionics

EKSO
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $60M

Market Cap: $41.5MFounded: 2005HQ: Richmond, United States

Overview

Ekso Bionics is a leader in robotic exoskeleton technology with a mission to enhance, amplify, and restore human function. Founded in 2005, the company has achieved commercial scale with its medical devices deployed in over 500 rehabilitation centers globally and has secured a pivotal Medicare coverage determination for its personal use device. Its strategy focuses on expanding clinical indications, driving insurance reimbursement, and leveraging its modular technology platform across healthcare and industrial markets.

Neurological RehabilitationSpinal Cord InjuryStrokeAcquired Brain InjuryMultiple Sclerosis

Technology Platform

A modular, powered exoskeleton platform integrating lightweight robotics, adaptive sensor-based software algorithms, and data analytics, designed to restore mobility in clinical and personal settings and augment human strength in industrial applications.

Funding History

4
Total raised:$60M
IPO$30M
Series B$20M
Series A$8M
Seed$2M

Company Timeline

2005Founded

Founded in Richmond, United States

2007Series A

Series A: $8.0M

2010Series B

Series B: $20.0M

2014IPO

IPO — $30.0M